DUBLIN--(BUSINESS WIRE)--The "Global Coagulation Testing Market - Forecasts From 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.
The global coagulation testing market is projected to grow at a CAGR of 7.65%, increasing from US$1,955.420 million in 2017 to US$3,042.760 million in 2023.
The global coagulation testing market is expected to witness significant growth during the given forecast period owing to the rising prevalence of the blood disorders.
Development of high-sensitivity POC coagulation testing techniques will also augment the coagulation testing market during the given forecast period.
However, high cost of the instruments coupled with the dearth of skilled work force might restrain the market for coagulation testing during the given time frame.
Major industry players profiled as part of the report are Diagnostica Stago, S.A.S., Sekisui Medical Co., Ltd. and Tcoag Ireland Ltd. among others.
Key Topics Covered
1. Introduction
2. Research Methodology
3. Key Findings of the Study
4. Market Dynamics
5. Global Coagulation Testing Market Forecast by Test Type
5.1.
Prothrombin Time Testing
5.2. Fibrinogen Testing
5.3.
Activated Clotting Time Testing
5.4. Platelet Function Tests
5.5.
Other
6. Global Coagulation Testing Market Forecast by End Users
6.1.
Hospitals and Clinics
6.2. Diagnostic Centres
6.3. Ambulatory
Care Centres
7. Global Coagulation Testing Market Forecast by Geography (US$ billion)
7.1.
North America
7.2. South America
7.3. Europe
7.4. Middle
East and Africa
7.5. Asia Pacific
8. Competitive intelligence
8.1. Market Share Analysis
8.2.
Strategies of Key Players
8.3. Recent Investments and Deals
9. Company Profiles
9.1. Abbott
9.2. Diagnostica Stago S.A.S.
9.3.
Roche Diagnostics
9.4. Thermo Fisher Scientific
9.5. r2
Diagnostics
9.6. Sekisui Medical Co. Ltd.
9.7. Tcoag Ireland
Ltd.
9.8. Coagulation Sciences LLC
9.9. RUSNANO Group
9.10.
Universal Biosensors
For more information about this report visit https://www.researchandmarkets.com/research/z5g99f/global?w=4
